tiprankstipranks
Trending News
More News >
inTEST Corporation (INTT)
:INTT

inTEST (INTT) AI Stock Analysis

Compare
268 Followers

Top Page

INTT

inTEST

(INTT)

Select Model
Select Model
Select Model
Neutral 56 (OpenAI - 5.2)
Rating:56Neutral
Price Target:
$9.00
▼(-6.93% Downside)
The score is held back primarily by weak financial performance (declining revenue and losses) and a negative P/E that limits valuation support. Offsetting factors include constructive technical momentum and a cautiously improving near-term outlook from the earnings call, highlighted by strong orders/backlog and guidance for a Q4 revenue rebound with better gross margin.
Positive Factors
Order and backlog growth / market diversification
Sustained, sizable order intake and a growing backlog provide multi-quarter revenue visibility and indicate demand across diversified end markets (auto/EV, defense/aero, industrial). This reduces single-market exposure and supports durable revenue recovery as backlog converts to shipments.
Conservative leverage and liquidity
Low leverage and a meaningful cash/liquidity buffer give the company financial flexibility to invest in R&D, support larger customer programs, and absorb cyclical downturns without immediate refinancing pressure, supporting longer-term operational stability.
Stable gross margin profile
A persistent ~41% gross margin implies structural pricing power or product mix resilience in test and measurement equipment. When volumes rebound, this margin base can leverage fixed costs and materially improve operating profitability over multiple quarters.
Negative Factors
Revenue decline and persistent profitability shortfall
Falling revenue alongside negative operating and net margins limits free cash generation and long-term shareholder returns. Without sustained revenue growth or margin expansion, the company may struggle to turn positive earnings and deliver consistent returns to investors.
Weak operating cash conversion and FCF pressure
Declining FCF growth and low operating-cash-to-income conversion signal potential liquidity strain and less internal funding for capex or strategic initiatives. Prolonged cash conversion weakness can force reliance on external financing or slow investment in product development.
Operational execution risk from technical delays
Execution issues that delay shipments highlight risks scaling new capabilities (life sciences, semiconductor). Repeated technical setbacks can erode customer trust, delay revenue recognition, and reduce the effective conversion of strong orders/backlog into sustained top-line growth.

inTEST (INTT) vs. SPDR S&P 500 ETF (SPY)

inTEST Business Overview & Revenue Model

Company DescriptioninTEST Corporation supplies test and process solutions for use in manufacturing and testing in automotive, defense/aerospace, industrial, life sciences, security, and semiconductor markets worldwide. The company operates through two segments, Thermal Products (Thermal) and Electromechanical Semiconductor Products (EMS). The Thermal segment offers ThermoStream products that are used in the semi market as a stand-alone temperature management tool, or in various electronic test applications; Thermal Chambers; Thermal Platforms; Thermonics temperature conditioning products that provide tempered gas or fluid; ultra-cold storage solutions, including biomedical freezers, refrigerators, and mobile storage solutions; EKOHEAT and EASYHEAT induction heating systems; and digital streaming and image capturing solutions. The EMS segment provides in2, Cobal, and LS series manipulators that hold various test heads and enable an operator to reposition a test head for alternate use with various probers or handlers on a test floor; and docking hardware products, which protect the interface contacts and ensure proper repeatable and precise alignment between the test head's interface board and the prober's probing assembly or the handler's test socket. This segment also offers tester interfaces that provide electrical connections between the tester and the wafer prober or integrated circuit (IC) handler; and scorpion flying probe test systems, which designs and manufactures robotics-based electronic test equipment, as well as provides application support services. Its products are used in production testing of wafers and specialized packaged ICs in back-end testing by semiconductor manufacturers. The company markets and sells its products to semiconductor manufacturers, third-party foundries, test and assembly providers, and original equipment manufacturers. inTEST Corporation was incorporated in 1981 and is headquartered in Mount Laurel, New Jersey.
How the Company Makes MoneyinTEST generates revenue through the sale of its core products and services, which include test and measurement equipment, temperature management systems, and automated test solutions. The company earns income from both direct sales and through long-term contracts with semiconductor manufacturers and electronics companies. Key revenue streams include product sales, service agreements, and maintenance contracts. Additionally, inTEST may benefit from partnerships with other technology firms, which can enhance its product offerings and expand its market reach, further contributing to its earnings.

inTEST Earnings Call Summary

Earnings Call Date:Nov 05, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Feb 27, 2026
Earnings Call Sentiment Neutral
While there were notable achievements in order growth and market diversification, the quarter faced challenges with revenue decline, technical delays, and a reported net loss. However, the company shows resilience with strong orders and improved financial flexibility, indicating potential for recovery.
Q3-2025 Updates
Positive Updates
Strong Order Growth
Orders increased to $37.6 million, the highest since Q2 2022, with a sequential $11.4 million increase in backlog. Automotive and defense/aerospace sectors showed significant growth, proving the success of market diversification strategies.
Record Alfamation Bookings
Alfamation bookings reached an all-time high, indicative of strong demand for test equipment from Tier 1 electronic suppliers. Orders from auto/EV doubled to $14.6 million.
Defense and Aerospace Sector Growth
Defense/aerospace orders more than doubled sequentially to $6.4 million due to increased demand for test equipment for next-generation weapon systems.
Year-Over-Year Order Increase
Overall orders were up 34.2% year-over-year, with significant increases in auto/EV, industrial, and defense/aerospace sectors.
Improved Financial Flexibility
Total debt reduced by $6.2 million in the first 9 months of 2025, resulting in $21.1 million in cash, cash equivalents, and restricted cash, with approximately $61 million in liquidity.
Negative Updates
Revenue Decline
Revenue for Q3 was $26.2 million, a decline of $1.9 million from Q2 and $4 million year-over-year. This was due to lower sales in defense/aerospace, auto/EV, and semi markets.
Technical Challenges Delaying Shipments
Technical challenges delayed approximately $2 million in shipments, affecting revenue and involving new capabilities for life sciences and semi markets.
Gross Margin Decline
Gross margin decreased 70 basis points sequentially and 440 basis points year-over-year due to lower volume and unfavorable product mix.
Net Loss Reported
The company reported a net loss of $0.9 million or $0.08 per share for Q3, with adjusted net loss at $0.02 per share.
Company Guidance
During the third quarter of 2025, inTEST Corporation experienced a mix of challenges and positive developments. Despite facing technical setbacks that delayed approximately $2 million in shipments, the company reported a strong increase in orders totaling $37.6 million, the highest since Q2 2022, driven by significant demand in the automotive and defense/aerospace markets. The quarter saw a sequential increase in backlog by $11.4 million, positioning the company well for future quarters. However, revenue for Q3 was $26.2 million, lower than Q2 and below the guidance range provided earlier, largely due to the shipment delays. Gross profit decreased by $1 million compared to the previous quarter, and gross margin declined by 70 basis points to 41.9%. Operating expenses were reduced to $12.2 million, reflecting cost-saving initiatives. The company recorded a net loss of $0.9 million or $0.08 per share, with an adjusted net loss of $0.02 per share and adjusted EBITDA of $0.4 million. InTEST anticipates a revenue rebound in Q4, forecasting between $30 million and $32 million, with a projected gross margin of 43%.

inTEST Financial Statement Overview

Summary
Financial performance is mixed: revenue declined (-3.32% TTM) and profitability remains negative (negative net profit and EBIT margins), offset by a stable gross margin (~41% TTM), low leverage (debt-to-equity 0.16), and modestly positive EBITDA margin (2.42% TTM). Cash flow shows pressure (FCF growth -6.40% TTM) but relatively good earnings-to-cash conversion (FCF to net income 0.88).
Income Statement
45
Neutral
The income statement shows a decline in revenue with a negative revenue growth rate of -3.32% TTM, indicating a challenging market environment. The gross profit margin is relatively stable at 41.29% TTM, but the company is experiencing negative net profit and EBIT margins, reflecting operational inefficiencies and potential cost management issues. The EBITDA margin remains positive at 2.42% TTM, suggesting some level of operational cash flow generation.
Balance Sheet
60
Neutral
The balance sheet indicates a moderate debt-to-equity ratio of 0.16 TTM, suggesting a conservative leverage position. However, the return on equity is negative at -2.25% TTM, highlighting challenges in generating returns for shareholders. The equity ratio is not explicitly calculated, but the company's equity position appears stable relative to its assets.
Cash Flow
55
Neutral
The cash flow statement shows a decline in free cash flow growth of -6.40% TTM, indicating potential liquidity pressures. The operating cash flow to net income ratio is 0.34 TTM, suggesting that cash generation from operations is not fully supporting net income. However, the free cash flow to net income ratio is relatively strong at 0.88 TTM, indicating efficient conversion of earnings into cash.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue117.61M130.69M123.30M116.83M84.88M53.82M
Gross Profit48.56M55.42M56.98M53.44M41.22M24.10M
EBITDA2.85M9.74M16.41M15.51M11.64M3.24M
Net Income-2.27M2.89M9.34M8.46M7.28M-895.00K
Balance Sheet
Total Assets148.28M152.29M134.83M110.07M103.91M62.03M
Cash, Cash Equivalents and Short-Term Investments21.10M19.83M45.26M13.43M21.20M10.28M
Total Debt18.84M26.04M17.46M22.49M26.72M7.26M
Total Liabilities46.41M52.50M38.55M45.11M49.08M17.28M
Stockholders Equity101.87M99.79M96.28M64.96M54.82M44.75M
Cash Flow
Free Cash Flow9.66M2.50M14.91M-2.75M9.85M2.59M
Operating Cash Flow10.92M3.82M16.20M-1.39M10.84M3.25M
Investing Cash Flow-1.26M-20.05M-1.29M-1.17M-21.37M-648.00K
Financing Cash Flow-7.32M-8.64M15.61M-3.73M21.73M-74.00K

inTEST Technical Analysis

Technical Analysis Sentiment
Positive
Last Price9.67
Price Trends
50DMA
8.08
Positive
100DMA
8.08
Positive
200DMA
7.45
Positive
Market Momentum
MACD
0.39
Negative
RSI
53.73
Neutral
STOCH
74.12
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For INTT, the sentiment is Positive. The current price of 9.67 is above the 20-day moving average (MA) of 8.79, above the 50-day MA of 8.08, and above the 200-day MA of 7.45, indicating a bullish trend. The MACD of 0.39 indicates Negative momentum. The RSI at 53.73 is Neutral, neither overbought nor oversold. The STOCH value of 74.12 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for INTT.

inTEST Risk Analysis

inTEST disclosed 3 risk factors in its most recent earnings report. inTEST reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

inTEST Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
57
Neutral
$254.07M-8.29-44.68%-21.59%-254.69%
56
Neutral
$116.97M-51.96-2.24%-2.20%-204.45%
53
Neutral
$1.37B-19.00-8.53%-4.50%-45.79%
50
Neutral
$104.35M-2.77-8.46%-7.79%10.04%
49
Neutral
$798.15M-92.01-6.97%-3.23%-122.16%
49
Neutral
$39.15M-1.29-38.72%16.01%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
INTT
inTEST
8.96
-0.18
-1.97%
AEHR
Aehr Test Systems
23.83
12.77
115.46%
ASYS
Amtech Systems
15.75
10.52
201.15%
COHU
Cohu
28.69
5.09
21.57%
MX
MagnaChip
2.86
-1.70
-37.28%
PXLW
Pixelworks
6.04
-4.64
-43.45%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 16, 2026